November 2020 - Page 11 of 27

WednesdayNov 18, 2020 11:16 am

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) to Commercialize Patented Hydrogen Filling Tech Through Subsidiary Contract with Leading Engineering Firm

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), via its 90%-owned subsidiary PowerTap Hydrogen Fueling Corp., has partnered with NASA-based hydrogen engineering firm Cryotek. The partnership calls for Cryotek to provide engineering and design for next-generation PowerTap hydrogen filling stations. The contract between PowerTap and Cryotek is scheduled to be deployed across North America in 2021. According to the eight-month contract, the engineering design will include a next-gen PowerTap onsite steam methane reformer (“SMR”) solution with the capability of producing more than 1,000 kg a day. The contract also outlines design for gaseous and liquid hydrogen storage solutions, CO2…

WednesdayNov 18, 2020 11:11 am

QualityStocksNewsBreaks – Tongji Healthcare Group Inc. (TONJ) Completes Acquisition of Social Media Influencer Firm with 90M-Strong Network

Tongji Healthcare Group (OTC: TONJ) has closed its acquisition of West of Hudson Group Inc., sole owner of a collection of Southern California scenic mansions known as the Clubhouse. The acquisition was completed on Nov. 12, 2020. The Clubhouse includes some of the most widely followed social media influencers who together have amassed an estimated follower base reaching more than 90 million. TONJ reported that industry trends point to the growing dominance of social media influencers in establishing market positioning and leadership among new consumer brands. One industry expert predicted global social media ad spend to gain 20% this year,…

WednesdayNov 18, 2020 10:39 am

QualityStocksNewsBreaks – Cannabis Global Inc. (CBGL) Announces Strategic Acquisition of Ethos Technology

Cannabis Global (OTC: CBGL), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies and investing in fast-growing cannabis markets, today announced its acquisition of Ethos Technology LLC. Ethos Technology is a Los Angeles-based startup specializing in ultra-secure cannabis transport containers for the commercial cultivation, processing and distribution sectors. Cannabis Global intends to leverage this technology to market a line of secure transport products under the brand name Comply Bag. “Having opened the first medical marijuana dispensary in Los Angeles back in 2004, my organization has struggled with securely transporting cannabis. That's why we invented this unique transport…

WednesdayNov 18, 2020 10:37 am

QualityStocksNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Places MiQLab(TM) System in Penn Vet Microbiology Laboratory

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that it has placed a MiQLab(TM) system into the clinical microbiology laboratory at the University of Pennsylvania’s School of Veterinary Medicine (Penn Vet) as part of its Early Access Program. Penn Vet provides animal patient testing at the Ryan Veterinary Hospital and for patients of practices across the United States, processing thousands of samples each year. “We are very excited to be placing our first completed commercial MiQLab system in the Penn Vet microbiology laboratory for their evaluation,” said Dr.…

WednesdayNov 18, 2020 10:07 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in A.G.P. Healthcare Symposium

CNS Pharmaceuticals (NASDAQ: CNSP) management will be participating in A.G.P.’s upcoming Virtual Healthcare Symposium. The symposium is scheduled for Nov. 19, 2020. Leaders of CNSP, a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, will be part of the event, which includes one-on-one virtual investor meetings. Potential investors who may want to attend the conference should contact an A.G.P. representative. CNS plans to start a Phase 2 clinical trial of its lead drug candidate Berubicin, which is designed to treat glioblastoma multiforme (“GBM”), an aggressive and incurable form of…

WednesdayNov 18, 2020 10:02 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Q3 2020 Financial Results, Provides Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, on Tuesday released financial results for the third quarter ended September 30, 2020. In addition, the company provided a business update and offered limited guidance for fiscal year 2021. “We are delighted with the results of the third quarter 2020, particularly in the measurable progress made in three important areas: (i) key operational and technical projects . . . ; (ii) revenue increases in our products and services offerings; and (iii) important restructuring…

WednesdayNov 18, 2020 9:37 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Featured in ROTH Equity Research Report

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “F2Q revenue was negatively impacted by retailers working through excess water inventory purchased during the pandemic period. However, WTER continues to build market share and retailer buying trends have now normalized. While we lower FY22 sales 7% to $63.1mm to be conservative, we note 1) WTER trades for 1.6x EV/Revenue versus larger, yet slower growth peers at ~6.0x; and 2) its penetration into the hospitality and CBD market offers significant potential upside to our/consensus FY22…

TuesdayNov 17, 2020 3:44 pm

QualityStocksNewsBreaks – Rritual Superfoods Inc. Delivers ‘Daily Dose’ Through Flagship Product Line

Rritual, a plant-based consumer brand, is a natural wellness innovator positioned at the heart of a fledgling industry rife with opportunity. According to Grand View Research Inc., the overall functional foods market is projected to reach $275.77 billion by 2025 (https://ibn.fm/5QUuu), and the demand for nutraceuticals and functional foods is now expected to surge even more than anticipated. Rritual has entered the market with its flagship product line of certified organic mushroom and adaptogen elixir mix powders. The company’s non-psychoactive wellness elixirs include a Chaga blend designed to boost immunity, a Lion’s Mane blend designed to support cognitive function and…

TuesdayNov 17, 2020 3:11 pm

Brain Scientific Inc. (BRSF) Offers Stock to Wider Pool of Investors Through Dalmore Group

BRSF announce partnership with Dalmore Group New product launch presents solution for growing need for rapid EEG testing due to COVID-19 pandemic Brain Scientific shose to extend proposed Reg A+ offering to attract additional investors Brain Scientific (BRSF), a commercial-stage healthcare company providing next-gen solutions to the neurology market, has announced a partnership with the Dalmore Group in a recent press release (https://ibn.fm/clcDx). "We are delighted to get the Dalmore Group on board and to be able to offer our stock to a much wider pool of investors,” said Brain Scientific chairman Boris Goldstein. “Our partners are experienced with Regulation…

TuesdayNov 17, 2020 2:53 pm

AzurRx BioPharma Inc. (NASDAQ: AZRX) Making Strides with MS1819 Clinical Trials for Cystic Fibrosis-Associated Pancreatic Insufficiency

Globally it is estimated that 70,000 people suffer from CF, with half the population in the United States The global CF therapeutics market size was valued at $4.62 billion in 2018 and is expected to reach an estimated $9.3 billion by 2026 AzurRx BioPharma’s MS1819, currently undergoing clinical trials, is a promising therapy for severe exocrine pancreatic insufficiency in patients with cystic fibrosis While still a relatively rare genetic disease, cystic fibrosis (“CF”) remains a dangerous condition that affects multiple body functions and organs, putting patients at risk of developing severe life-threatening illnesses. This is why the need for innovative…

Site Search

Company Search

Month: November 2020